Electrosurgery is the use of an electrical current to cut, coagulate, desiccate, or fulgurate biological tissue. Electricity is used to cause tissue thermal destruction via dehydration, coagulation, or vaporization. The tissue acts as a barrier to the passing current, converting it to heat. The two types of electrosurgery used are high-frequency electrosurgery and electrocautery.
Electro surgery has a wide range of applications in dentistry, laparoscopy, and chronic diseases (related to the kidney and abdomen, among others), with dermatological treatments being the most prominent According to the World Health Organization (WHO), skin cancer affects one out of every three cancer patients. As a result, a large number of patients choose electrosurgery.
Curettage and electrosurgery treatment for skin cancer have a cure rate of around 99 percent for basal cell cancer, making electrosurgery a co-therapy for the treatment.
Easy electrosurgery procedures and a wide range of applications are expected to drive the electrosurgery market forward.
Colorectal cancer is the second most common cancer in both men and women, according to the World Health Organization (WHO). Furthermore, the American Cancer Society estimates that in 2017, approximately 135,430 people will be diagnosed with colorectal cancer, with 40 percent already in an advanced stage of the disease.
According to the National Institute on Aging's (NIA) new report, An Aging World: 2015, 8.5 percent of people worldwide (617 million) are 65 or older and are at a higher risk of developing chronic diseases, which increases demand for electrosurgery procedures. Technological advancements are expected to improve the performance of electrosurgical generators, ensuring the delivery of appropriate heat energy for patient treatment.
Technological advancements, a growing geriatric population, and an increase in the prevalence of chronic diseases related to the kidneys and heart, among other factors, are expected to drive growth in the electrosurgery market.
Electrosurgery is not recommended for patients who have cochlear implants, cardiac and gastric pacemaker implants, or Implantable Cardioverter Defibrillators (ICDs), as it can have fatal consequences. This is a significant impediment to market growth.